Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02370888
Brief Title: Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease (UF-BMT-MRD-101)

First Submitted : February 10, 2015
First Submitted that Met QC Criteria : February 24, 2015
First Posted : February 25, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 23, 2019
Last Update Posted : August 26, 2019 (Estimate)